+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Invasive fungal infections in low-risk liver transplant recipients: a multi-center prospective observational study



Invasive fungal infections in low-risk liver transplant recipients: a multi-center prospective observational study



American Journal of Transplantation 6(2): 386-391



Prevention of invasive fungal infections (IFIs) in orthotopic liver transplant (OLT) recipients utilizing postoperative systemic antifungal prophylaxis, typically with fluconazole, is justified among those at high risk for IFI. Use of postoperative antifungal prophylaxis for low-risk OLT recipients is widely practiced but not universally accepted nor supported by data.

(PDF emailed within 0-6 h: $19.90)

Accession: 012799482

Download citation: RISBibTeXText

PMID: 16426325

DOI: 10.1111/j.1600-6143.2005.01176.x


Related references

Cytomegalovirus Infections in Lung and Hematopoietic Cell Transplant Recipients in the Organ Transplant Infection Prevention and Detection (OTIP) Study: a Multi-Year, Multi-Center Prospective Cohort Study. Transplant Infectious Disease, 2018

Risk factors for invasive fungal infections in liver transplant recipients. Chinese Medical Journal 125(2): 400-400, 2012

Prospective screening in liver transplant recipients by panfungal PCR-ELISA for early diagnosis of invasive fungal infections. Liver Transplantation 13(7): 1011-1016, 2007

The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland. American Journal of Medicine 103(2): 106-113, 1997

Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients. Transplantation Proceedings 37(9): 3965-3967, 2006

Risk factors for early invasive fungal infections in pediatric liver transplant recipients. Mycoses, 2018

Prophylaxis with caspofungin for invasive fungal infections in high-risk liver transplant recipients. Transplantation 87(3): 424-435, 2009

Intestinal fungal and parasitic infections in kidney transplant recipients: a multi-center study. Saudi Journal of Kidney Diseases and Transplantation 23(4): 677-683, 2012

Risk factors for invasive fungal infections in liver transplant recipients receiving tacrolimus as primary immunosuppression. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 36(0): 242, 1996

Invasive fungal infections in allogeneic and autologous stem cell transplant recipients: a single-center study of 166 transplanted patients. Transplant Infectious Disease 9(3): 189-195, 2007

Micafungin versus amphotericin B lipid complex for the prevention of invasive fungal infections in high-risk liver transplant recipients. Transplantation 96(6): 573-578, 2013

Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients: a multicenter retrospective study. Italian Study Group of Fungal Infections in Thoracic Organ Transplant Recipients. Transplantation 70(1): 112-116, 2000

Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high-risk patients. Journal of Antimicrobial ChemoTherapy 52(5): 813-819, 2003

Randomized, double-blind trial of anidulafungin versus fluconazole for prophylaxis of invasive fungal infections in high-risk liver transplant recipients. American Journal of Transplantation 14(12): 2758-2764, 2015

Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients. A randomized, placebo-controlled study. Transplantation 59(1): 45-50, 1995